Meeting
2017 ASCO Annual Meeting
Upfront short course radiotherapy (SCRT) in metastatic rectal cancer (mRC): A way forward.
Authors
Shanu Jain
Tata Memorial Hospital, Mumbai, India
Shanu Jain , Reena Engineer , Vikas S. Ostwal , Anant Ramaswamy , Supriya Chopra , Ashwin Desouza , Shirley Christabel Lewis , Suprita Arya , Prachi Patil , Avanish Saklani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3570)
DOI
10.1200/JCO.2017.35.15_suppl.3570
Abstract #
3570
Poster Bd #
193
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
First Author: Emerson Yu-sheng Chen
Poster
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
First Author: Nicholas Adam Bosma
Poster
2016 ASCO Annual Meeting
A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial.
First Author: Michael Michael
Poster
2014 ASCO Annual Meeting
Surveillance for asymptomatic recurrence in resected stage III colon cancer (CC): Does it result in a more favorable outcome?
First Author: Martin Smoragiewicz